Prescribed HRT (Trans Female)
What Is Prescribed HRT?
Prescribed HRT means obtaining estrogen, anti-androgens, and progesterone through a licensed healthcare provider — typically an endocrinologist, primary care physician, or specialised gender clinic. Your care is medically supervised with regular blood tests and dose adjustments.
Routes to Access
Informed Consent Model
Under informed consent, you sign a form acknowledging the risks and benefits of HRT, and treatment begins without requiring a therapist's letter or formal diagnosis of gender dysphoria.
- Common in: United States (Planned Parenthood, many LGBTQ+ clinics), Australia (certain clinics), parts of Europe
- Pros: Fastest path to prescribed care; no gatekeeping
- Cons: Not available everywhere; some providers still require a letter
Traditional Model (Therapist Letter Required)
You obtain a diagnosis of gender dysphoria from a mental health professional, who then provides a letter recommending HRT.
- Common in: Many European countries, UK (NHS Gender Identity Clinics), parts of Asia
- Pros: Structured care; may include counselling support
- Cons: Long waiting lists (up to 5–7 years in some countries), potential for gatekeeping
Private Healthcare
- Common in: UK (private gender clinics), US (out-of-pocket), countries with limited public options
- Pros: Shorter waiting times; more choice of providers
- Cons: Expensive; costs vary widely
Common Prescribed Regimens
| Regimen | Typical Prescription |
|---|---|
| Oral estradiol | 2–8 mg/day (often split 2× daily) |
| Transdermal patches | 50–200 mcg/24h, changed twice weekly |
| Estradiol gel | 1–4 pumps/day (Oestrogel, Sandrena) |
| Injectable EV | 2–8 mg every 5 days |
| Injectable EC | 1–5 mg every 7 days |
| Spironolactone | 50–200 mg/day (often 100 mg) |
| Cyproterone acetate | 10–12.5 mg/day |
| Finasteride | 1–5 mg/day (for hair preservation) |
Pros of Prescribed HRT
| Benefit | Details |
|---|---|
| Medical supervision | Regular blood tests and professional dose adjustments |
| Quality-controlled medication | Pharmaceutical-grade products from regulated pharmacies |
| Insurance coverage | Many insurance plans cover HRT partially or fully |
| Legal protection | Prescribed HRT is legal and recognised by medical authorities |
| Monitoring for side effects | Blood pressure, liver function, prolactin, and other markers tracked |
| Access to additional care | Referrals for voice training, hair removal, surgery if needed |
Cons of Prescribed HRT
| Drawback | Details |
|---|---|
| Long waiting lists | Up to 5–7 years in some countries (especially UK NHS) |
| Gatekeeping | Some providers impose unnecessary barriers or have outdated protocols |
| Inflexible dosages | Some providers are unwilling to prescribe higher doses or specific medications |
| Limited medication options | Some countries restrict injectable estradiol or certain anti-androgens |
| Cost (private) | Can be expensive without insurance coverage |
| Pathologisation | Being treated as having a "disorder" can feel dysphoric |
| Outdated protocols | Some providers still use high-dose CPA (50+ mg/day) or refuse transdermal options |
Questions to Ask a Potential Provider
- What is your experience treating trans patients?
- Do you use the informed consent model or require a therapist letter?
- What are your target hormone ranges (E2, T)?
- Are you willing to prescribe injectable estradiol or transdermal routes?
- Do you monitor prolactin, blood pressure, and liver function?
- Are you familiar with WPATH SOC8 guidelines?
Red Flags in a Provider
- Insists on using birth control pills (ethinylestradiol) instead of bioidentical estradiol
- Refuses to prescribe anti-androgens
- Targets testosterone levels above 50 ng/dL
- Requires RLE (real-life experience) before prescribing
- Unwilling to learn or consult guidelines
References
WPATH (2022). Standards of Care, Version 8. https://www.tandfonline.com/doi/full/10.1080/26895269.2022.2100644
Hembree WC, et al. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons. JCEM. https://academic.oup.com/jcem/article/102/11/3869/4157558
Coleman E, et al. (2022). Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health. https://www.tandfonline.com/doi/full/10.1080/26895269.2022.2100644